Filing Details
- Accession Number:
- 0001062993-23-023239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-28 16:31:17
- Reporting Period:
- 2023-12-26
- Accepted Time:
- 2023-12-28 16:31:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1205922 | Vaccinex Inc. | VCNX | Pharmaceutical Preparations (2834) | 161603202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1748247 | Van Strydonck, Gerald E. | C/O Vaccinex, Inc. 1895 Mount Hope Avenue Rochester NY 14620 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-12-26 | 3,149 | $0.72 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $204.00 | 2027-09-15 | 426 | 426 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $78.90 | 2029-03-30 | 166 | 166 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $116.70 | 2020-05-15 | 514 | 514 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $82.80 | 2029-06-29 | 159 | 159 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $107.55 | 2029-09-27 | 123 | 123 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $72.75 | 2029-12-28 | 182 | 182 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $59.25 | 2021-05-14 | 1,045 | 1,045 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $32.25 | 2022-05-11 | 1,905 | 1,905 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $16.80 | 2023-05-12 | 3,550 | 3,550 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $6.15 | 2024-05-11 | 9,589 | 9,589 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2027-09-15 | 426 | 426 | Direct |
| 2029-03-30 | 166 | 166 | Direct |
| 514 | 514 | Direct | |
| 2029-06-29 | 159 | 159 | Direct |
| 2029-09-27 | 123 | 123 | Direct |
| 2029-12-28 | 182 | 182 | Direct |
| 1,045 | 1,045 | Direct | |
| 1,905 | 1,905 | Direct | |
| 3,550 | 3,550 | Direct | |
| 9,589 | 9,589 | Direct |
Footnotes
- Exercisable in full as of the date of this report.
- This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
- This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
- This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
- This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
Billionaire Hedge Funds
